Glucose pills: glucose tablets for lows versus pills that lower blood sugar

The two can appear in the same person's kit. Someone whose diabetes pills can push blood sugar too low may carry glucose tablets to correct that low. That overlap is the reason the names get confused, and the reason it matters which one a search, a pharmacy shelf or a care plan means.

The ADA's consumer guidance calls it the 15-15 rule: 15 grams of fast-acting carbohydrate, then a recheck after 15 minutes. If glucose is still below 70 mg/dL, or a continuous glucose monitor does not show it rising, the rule repeats with another 15 grams; once it is above 70 mg/dL and no meal is due soon, the ADA suggests a snack with protein and carbohydrate ^[1]. Glucose tablets are the first example the ADA lists, alongside glucose gel, half a cup of juice or regular soda, and a tablespoon of sugar ^[1].

The professional version sits in Section 6 of the ADA Standards of Care 2026. It names glucose in the 15 to 20 gram range as the preferred treatment for a conscious person with hypoglycemia, with a repeat dose if glucose is still low 15 minutes later and a meal or snack once it has recovered ^[2]. The same section grades lows by level: level 1 below 70 mg/dL, level 2 below 54 mg/dL, and level 3 a severe event in which the person needs someone else's help ^[2]. The 2026 edition added a recommendation that oral glucose be stocked in first-aid kits in schools, workplaces and other public settings ^[2].

How many glucose tablets make 15 grams

Because the ADA puts each tablet at 4 to 5 grams ^[1], 15 grams is usually three or four tablets. The count depends on the product, so the nutrition label, not the number of tablets, is what the rule refers to. This is arithmetic on the ADA's figure, not a dosing instruction; a care team sets the plan for an individual.

When tablets are not enough

Glucose tablets need someone awake and able to chew and swallow. For severe (level 3) lows, the Standards of Care recommend that glucagon be prescribed for people at risk of level 2 or 3 hypoglycemia, so it is on hand when swallowing is not safe ^[2].

One systematic review addressed exactly this. It pooled three randomised trials and one observational study covering more than 700 treated lows in awake people with diabetes ^[4]. The dietary sugars tested included sucrose, fructose, orange juice, jelly beans, Mentos, Skittles and milk. Fifteen minutes after treatment, symptoms had resolved less often with dietary sugars than with glucose tablets, a risk ratio of 0.89 (95% CI 0.83 to 0.95) ^[4]. The authors concluded that glucose tablets should be considered first when available ^[4].

The ADA's own list still includes juice, regular soda and sugar as acceptable 15-gram options ^[1], and it notes that foods with chocolate or peanut butter are not the best choice for treating a low ^[1]. The practical advantage of a tablet is that its grams are printed on the label, which makes the 15-gram count easier to hit without overshooting.

Whether someone with type 2 diabetes needs to carry glucose depends mostly on their medicines. In a network meta-analysis of 39 randomised trials and 17,860 people, adding sulfonylureas, glinides, basal insulin or biphasic insulin to metformin raised the risk of hypoglycemia compared with placebo, while GLP-1 drugs did not ^[5]. The ADA Standards of Care 2026 describe the same split: insulin and insulin secretagogues (sulfonylureas and meglitinides) carry a hypoglycemia risk, and metformin, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists and thiazolidinediones carry little risk when used without them ^[3].

• Insulin, at any stage of type 2 diabetes: lows are a known effect, which is why the ADA singles out people on insulin ^[1].
• Sulfonylureas (glipizide, glimepiride, glyburide) and meglitinides: they make the pancreas release insulin regardless of the glucose level ^[3].
• Metformin, an SGLT2 inhibitor or a GLP-1 drug alone: lows are uncommon ^[5][3], although a care team may still advise carrying glucose for exercise, illness or a change in treatment.

Our metformin versus insulin comparison goes further into why insulin changes the hypoglycemia picture.

"Glucose pills for diabetes", "blood sugar tablets" and "sugar tablets for diabetics" usually refer to oral glucose-lowering drugs. The ADA Standards of Care 2026 group them by class and describe how a clinician chooses among them by heart and kidney disease, weight goals, hypoglycemia risk, cost and side effects ^[3].

Oral semaglutide is the GLP-1 drug in tablet form; it was tested in people with type 2 diabetes at high cardiovascular risk in the SOUL trial ^[6]. The injectable and oral forms are covered on the semaglutide record. For the full list of pills and injections, see type 2 diabetes treatments; for an SGLT2 example in depth, Jardiance for type 2 diabetes; and for what has been approved recently, new diabetes medications.

None of these pills is sold over the counter in the US, and no over-the-counter product replaces them. Some people also arrive here looking for a way off medication altogether; the evidence on that is on our page about type 2 diabetes remission.

This site does not rank brands. The evidence does not separate one brand of glucose tablet from another; what it compares is glucose tablets against other sugars, where tablets resolved symptoms more often at 15 minutes ^[4]. What does differ between products is the grams per tablet, which sets how many make up the 15 to 20 grams the ADA describes ^[2][1]. Flavour, chewability and whether a gel suits someone who struggles to chew are practical choices, not clinical ones. For people whose type 2 diabetes is treated without insulin or a sulfonylurea, the more useful question is often whether they need glucose on hand at all, which the section above covers ^[5].